FDA ' s role in balancing innovation, regulation, safety during pandemic

Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory " agility " during the COVID-19 pandemic.
Source: Healthcare ITNews Videos - Category: Information Technology Source Type: video